<div class="wrapper about-wrapper-index visible-xs visible-sm visible-lg advisor">
	<div class="container pad-space">
			 <div class="advisors">
			<h3>Dr. Stephan C Schuster</h3>
			<p>Dr. Stephan C Schuster is currently Research Director and Professor at the Singapore Centre on Environmental Life Sciences Engineering, Nanyang Technical University, Singapore. Dr .Schuster has over 15 years of experience setting up and operating centralized sequencing core labs at Max Plank Institute in Germany and Penn State in the US. He won the Science magazine’s break through of the year award in 2006 (runner up) and 2008 (Top 10), was awarded the Time Magazine’s top ten Scientific discoveries in 2008 and with W. Miller was among Time magazine’s top 100 most influential people of 2009.</p>
			</div>
    
    <div class="advisors">
			<h3>Dr. Ishwar C. Verma</h3>
			<p>Dr. I. C. Verma is currently the head of Department of Genetic Medicine at Sri Ganga Ram Hospital, New Delhi. He was earlier Professor of Pediatrics and Genetics in AIIMS, New Delhi. He received genetics training in the UK, USA & Switzerland. He is a Fellow of the Royal College of Physicians, London, the American Academy of Pediatrics, and the National Academy of Medical Sciences, New Delhi. He has received a number of national awards – Ranbaxy Science Award, ICMR, NAMS and BC Roy Medical Council award. He is a Member and Vice-chairman of the Ethics Committee of the International Human Genome Organization (HUGO) and serves as an adviser in genetics to the WHO in Geneva, and to Roche Genetics in Basel. He has recently been mentioned in The Limca Book of Records 2003 as a pioneer in genetics in India. He has vast experience in genetic counseling, serving about 2000 cases with genetic problems every year, and bringing the benefits of genetics and genomics to large number of patients.</p>

			<h3>Dr. Satish Menon</h3>
			<p>Dr. Satish Menon is the founder and CEO of UV Labs, a company focused on building innovative products and technologies to help solve the increasingly complex issues facing higher education today, in sectors such as healthcare and information technology.</p>
            <p>Throughout his career, Satish has led the development of multiple technological innovations in education and digital media, including the development of data-driven personalized learning management platforms, several mobile products, and a suite of education-to-career tools for post-secondary learners..</p>
            <p>Prior to founding UV Labs, Satish was the Chief Technology Officer for Apollo Group, a Fortune 500 company and one of the world’s largest private education providers. In that role and in his term as CIO for the company, Satish was responsible for the design and development of all consumer-facing technology, as well creating cloud-enabled education-as-a-service solutions for the company. Prior to his work at Apollo Group, Satish held roles as Chief Architect of Yahoo Media, Engineering General Manager for Video Platforms and Vice-President in the Consumer Platforms team at Yahoo.</p>
            <p>Satish earned his Ph.D. in computer science from the Georgia Institute of Technology, as well as an M.S. in computer science and an M.S. in mechanical engineering from the New Jersey Institute of Technology. Deeply passionate about higher education and the role technology can play in transforming it, Satish holds several patents (issued and pending) in the areas of personalized learning delivery, content management and video technologies.</p>
	</div>
    
    
    <div class="advisors">
			<h3>Dr. C.N. Ramchand</h3>
			<p>Dr. C.N. Ramchand is the CEO of Saksin Lifesciences and has a strong expertise in drug discovery and research, and has had a highly successful career across India, EU and the US. Prior to joining Saksin, Dr Ramchand was the CEO of Laila Pharmaceuticals and a Director at KEMIN Pharma India (a subsidiary of Kemin Pharma Belgium BVBA) and was simultaneously holding a position as Director of Research and Development, Kemin Industries South Asia Pvt. Ltd (a part of Kemin Industries Inc., Demoines, USA). In addition, Dr Ramchand was also a global executive team member of Kemin Industries.</p>
			<p>Dr. Ramchand holds a PhD in Biochemistry from MS University Baroda. He also served as assistant professor from 1982-84 at MS University. He has also obtained his M Phil from the same university. He holds a Masters degree in Chemistry from the University of Kerala. He is also the 3 time winner of the Young Scientist award winner from Charing Cross and Westminster Medical School, UK for the work of the role of membrane pathology in schizophrenia and the development of EPA as a therapy for schizophrenia. He has extensive experience in basic research activities having handled prestigious projects in the US and UK, both at Universities and Pharma Industries. He has over 25 years of rich experience in the areas of teaching, basic research, drug discovery programmes , study of disease mechanisms, guiding M Sc. / Ph D. students and setting up a Research facility.</p>
            <p>Prior to the assignment at Kemin Industries, Dr Ramchand served as Vice President and Head of Drug Discovery Research (1999-2004) at Sun Pharmaceuticals Industries- the largest Pharma company in India (currently No 1 in-terms of market capitalization). He was closely involved in setting up a multi million dollar Drug Discovery center including design and development of laboratories. He had developed 3 molecules while at Sun Pharma which are currently in Phase II trials. He has also held the position of Joint Coordinator and Head of the Laboratory research program in Biomedical sciences, University of Sheffield and Northern General Hospital Sheffield, UK (1994-1999)- a prestigious University Position. Prior to this, he was the Sr. Scientist and Project Head at Institute of Biological Psychiatry at University of Wales, Bangor UK (1990-1994). He has also worked as Senior Research Officer at the Biochemistry Department, University of North Wales, Bangor, UK (1987-1990). Prior to this he was also a postdoctoral fellow at University of South Carolina, USA (1984-1987).</p>
            <p>Dr. Ramchand has published over 70 peer-reviewed papers in international journals, edited 5 books ( he’s currently writing two books on drug discovery with Tata McGraw Hill) and has applied for over 10 patents. He has made over 100 research presentations at international conferences world wide and is also currently a Sr. Visiting fellow at the University of Sheffield and University of New Castle Upon-Tyne, UK, and at the Slovakian Academy of Sciences, Slovak Republic. He has a very close research association with State University of New York at Buffalo, USA and Florida International University (Miami, USA) and also is an adjunct faculty and PhD guide at the MS University of Baroda. Currently, Dr Ramchand is an Honorary Visiting Professor to European Nanotechnology consortium at University of Newcastle at UK.</p>
	</div>
    
    
     <div class="advisors">
			<h3>Dan Peterson</h3>
			<p>Mr. Peterson has over 45 years of work experience in the financial services sector in USA. Based out of the San Francisco Bay area (California), he is currently the founder and President of ePay Healthcare. Prior to that, he was the President and CEO of CASHNet for over 25 years. Before that, he founded and partnered at PBL Associates. Mr. Peterson completed his education from the University of California at Berkeley.</p>
	</div>
    
    
	</div>
</div>